Back to Search
DYLAN HAGERTY, DMD
DMD
Dentist
NPI: 1780947416Individual
Specialties, Licenses & Credentials
DentistPrimary
Dentist
Code: 122300000X
DN19794(FL)
Research & Publications (14)
Rituximab inhibits structural joint damage in patients with rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitor therapies.
PMID 18388156·Ann Rheum Dis·2009
3-trial
The oblique view: an alternative approach for ultrasound-guided central line placement.
PMID 18829208·J Emerg Med·2009
8-other
Plasma advanced glycation endproduct, methylglyoxal-derived hydroimidazolone is elevated in young, complication-free patients with Type 1 diabetes.
PMID 19154730·Clin Biochem·2009
8-other
Very high and increasing incidence of type 1 diabetes mellitus in Newfoundland and Labrador, Canada.
PMID 18221421·Pediatr Diabetes·2008
8-other
Study of glucose profiles with continuous glucose monitoring in adolescents with poorly controlled type 2 diabetes mellitus.
PMID 18825872·J Pediatr Endocrinol Metab·2008
3-trial
Donna Hagerty: a source of inspiration, information and hope for parents and their children. Interview by Tara Tosh-Kennedy.
PMID 17410925·Can Nurse·2007
8-other
Plasma methylglyoxal and glyoxal are elevated and related to early membrane alteration in young, complication-free patients with Type 1 diabetes.
PMID 17594057·Mol Cell Biochem·2007
4-observational
Abatacept for rheumatoid arthritis refractory to tumor necrosis factor alpha inhibition.
PMID 16162882·N Engl J Med·2005
3-trial
Costimulation blockade with belatacept in renal transplantation.
PMID 16120857·N Engl J Med·2005
3-trial
Rational development of LEA29Y (belatacept), a high-affinity variant of CTLA4-Ig with potent immunosuppressive properties.
PMID 15707398·Am J Transplant·2005
7-preclinical
Development of a chimeric anti-CD40 monoclonal antibody that synergizes with LEA29Y to prolong islet allograft survival.
PMID 15611281·J Immunol·2005
7-preclinical
High incidence of childhood type 1 diabetes in the Avalon Peninsula, Newfoundland, Canada.
PMID 15047643·Diabetes Care·2004
8-other
Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig.
PMID 14614165·N Engl J Med·2003
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 3001 ENTERPRISE RD E
CLEARWATER, FL 33759 - Phone
- (727) 791-9393
Quick Facts
- NPI
- 1780947416
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 2
- Publications
- 14
Are you this provider?
Claim Your Profile